Maximilian Lennartz

24PUBLICATIONS
73CO-AUTHORS
Molecular targetsPredictive and prognostic markersFoetal development and medicineHaematological tumoursCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 15, 2026
MRE11 Deficiency Occurs in a Small Group of Cancers from Various Different Tumor Entities.

|Mar 13, 2026
Pattern and Clinical Significance of CA19-9 Expression in Human Cancer: A Tissue Microarray Study on 14,966 Tumors.

Nina Schraps, Anne Menz, Florian Viehweger

|Jan 24, 2026
PTEN Deletions Are Associated With Tumor Progression But Unrelated to Patient Prognosis in Muscle-Invasive Urothelial Bladder Carcinomas: A Large Multi-Center Validation Study on 2710 Urothelial Bladder Carcinomas.

Martina Kluth, Henning Plage, Kira Furlano

|Dec 30, 2025
Differential Androgen Receptor Expression Across Bladder Cancer Stages and Its Link to Poor Outcomes.

Henning Plage, Nadine Biernath, Kira Furlano

|Nov 27, 2025
Results of the First Folate Receptor Alpha Testing Trial by the German Quality Assurance Initiative in Pathology (QuIP<sup>®</sup>).

Alexander Scheiter, Sven Mattern, Verena Gassenmaier

|Nov 04, 2025
High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer.

Neele Heckmann, Henning Plage, Ronald Simon

Pageof 4

Frequent Collaborators

22 joint publications

Ronald Simon

14 joint publications

Till Sebastian Clauditz

12 joint publications

Claudia Hube-Magg

9 joint publications

Davin Dum